125 related articles for article (PubMed ID: 10514077)
21. The purine nucleoside phosphorylase from Trichomonas vaginalis is a homologue of the bacterial enzyme.
Munagala N; Wang CC
Biochemistry; 2002 Aug; 41(33):10382-9. PubMed ID: 12173924
[TBL] [Abstract][Full Text] [Related]
22. Crystal structure of adenosine kinase from Toxoplasma gondii at 1.8 A resolution.
Cook WJ; DeLucas LJ; Chattopadhyay D
Protein Sci; 2000 Apr; 9(4):704-12. PubMed ID: 10794412
[TBL] [Abstract][Full Text] [Related]
23. Expression in Escherichia coli of a recombinant adenosine kinase from Saccharomyces cerevisiae: purification, kinetics and substrate analyses.
Barrado P; Rodríguez MJ; Jiménez A; Fernández Lobato M
Yeast; 2003 Oct; 20(13):1145-50. PubMed ID: 14558146
[TBL] [Abstract][Full Text] [Related]
24. Substrate analogs induce an intermediate conformational change in Toxoplasma gondii adenosine kinase.
Zhang Y; El Kouni MH; Ealick SE
Acta Crystallogr D Biol Crystallogr; 2007 Feb; 63(Pt 2):126-34. PubMed ID: 17242506
[TBL] [Abstract][Full Text] [Related]
25. Adenosine metabolism in Toxoplasma gondii: potential targets for chemotherapy.
el Kouni MH
Curr Pharm Des; 2007; 13(6):581-97. PubMed ID: 17346176
[TBL] [Abstract][Full Text] [Related]
26. Carbocyclic 6-benzylthioinosine analogues as subversive substrates of Toxoplasma gondii adenosine kinase: biological activities and selective toxicities.
Al Safarjalani ON; Rais RH; Kim YA; Chu CK; Naguib FN; El Kouni MH
Biochem Pharmacol; 2010 Oct; 80(7):955-63. PubMed ID: 20541538
[TBL] [Abstract][Full Text] [Related]
27. Characterization of Toxoplasma gondii glyoxalase 1 and evaluation of inhibitory effects of curcumin on the enzyme and parasite cultures.
Goo YK; Yamagishi J; Ueno A; Terkawi MA; Aboge GO; Kwak D; Hong Y; Chung DI; Igarashi M; Nishikawa Y; Xuan X
Parasit Vectors; 2015 Dec; 8():654. PubMed ID: 26694921
[TBL] [Abstract][Full Text] [Related]
28. Toxoplasma gondii tachyzoites possess an unusual plasma membrane adenosine transporter.
Schwab JC; Afifi Afifi M; Pizzorno G; Handschumacher RE; Joiner KA
Mol Biochem Parasitol; 1995 Mar; 70(1-2):59-69. PubMed ID: 7637715
[TBL] [Abstract][Full Text] [Related]
29. Toxoplasma gondii cyclic GMP-dependent kinase: chemotherapeutic targeting of an essential parasite protein kinase.
Donald RG; Allocco J; Singh SB; Nare B; Salowe SP; Wiltsie J; Liberator PA
Eukaryot Cell; 2002 Jun; 1(3):317-28. PubMed ID: 12455981
[TBL] [Abstract][Full Text] [Related]
30. Molecular characterization of recombinant mouse adenosine kinase and evaluation as a target for protein phosphorylation.
Sahin B; Kansy JW; Nairn AC; Spychala J; Ealick SE; Fienberg AA; Greene RW; Bibb JA
Eur J Biochem; 2004 Sep; 271(17):3547-55. PubMed ID: 15317590
[TBL] [Abstract][Full Text] [Related]
31. Heterologous expression and characterization of the bifunctional dihydrofolate reductase-thymidylate synthase enzyme of Toxoplasma gondii.
Trujillo M; Donald RG; Roos DS; Greene PJ; Santi DV
Biochemistry; 1996 May; 35(20):6366-74. PubMed ID: 8639582
[TBL] [Abstract][Full Text] [Related]
32. Toxoplasma gondii: siRNA can mediate the suppression of adenosine kinase expression.
Yu L; Gao YF; Qiao ZP; Li CL; Li X; Shen JL
Exp Parasitol; 2008 Jan; 118(1):96-102. PubMed ID: 17888425
[TBL] [Abstract][Full Text] [Related]
33. The carboxyltransferase activity of the apicoplast acetyl-CoA carboxylase of Toxoplasma gondii is the target of aryloxyphenoxypropionate inhibitors.
Jelenska J; Sirikhachornkit A; Haselkorn R; Gornicki P
J Biol Chem; 2002 Jun; 277(26):23208-15. PubMed ID: 11980900
[TBL] [Abstract][Full Text] [Related]
34. Identification and characterization of a unique adenosine kinase from Mycobacterium tuberculosis.
Long MC; Escuyer V; Parker WB
J Bacteriol; 2003 Nov; 185(22):6548-55. PubMed ID: 14594827
[TBL] [Abstract][Full Text] [Related]
35. The partial purification and characterization of adenosine kinase from Entamoeba histolytica.
Lobelle-Rich PA; Reeves RE
Am J Trop Med Hyg; 1983 Sep; 32(5):976-9. PubMed ID: 6312825
[TBL] [Abstract][Full Text] [Related]
36. Toxoplasma gondii purine nucleoside phosphorylase biochemical characterization, inhibitor profiles, and comparison with the Plasmodium falciparum ortholog.
Chaudhary K; Ting LM; Kim K; Roos DS
J Biol Chem; 2006 Sep; 281(35):25652-8. PubMed ID: 16829527
[TBL] [Abstract][Full Text] [Related]
37. IMP dehydrogenase from the protozoan parasite Toxoplasma gondii.
Sullivan WJ; Dixon SE; Li C; Striepen B; Queener SF
Antimicrob Agents Chemother; 2005 Jun; 49(6):2172-9. PubMed ID: 15917510
[TBL] [Abstract][Full Text] [Related]
38. Plastid-associated porphobilinogen synthase from Toxoplasma gondii: kinetic and structural properties validate therapeutic potential.
Shanmugam D; Wu B; Ramirez U; Jaffe EK; Roos DS
J Biol Chem; 2010 Jul; 285(29):22122-31. PubMed ID: 20442414
[TBL] [Abstract][Full Text] [Related]
39. A novel DNA repair enzyme containing RNA recognition, G-patch and specific splicing factor 45-like motifs in the protozoan parasite Toxoplasma gondii.
Dendouga N; Callebaut I; Tomavo S
Eur J Biochem; 2002 Jul; 269(14):3393-401. PubMed ID: 12135477
[TBL] [Abstract][Full Text] [Related]
40. The biochemical basis for resistance to adenine arabinoside in a mutant of Toxoplasma gondii.
Pfefferkorn ER; Pfefferkorn LC
J Parasitol; 1978 Jun; 64(3):486-92. PubMed ID: 207846
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
